Anna C Calkin

Anna C Calkin

UNVERIFIED PROFILE

Are you Anna C Calkin?   Register this Author

Register author
Anna C Calkin

Anna C Calkin

Publications by authors named "Anna C Calkin"

Are you Anna C Calkin?   Register this Author

33Publications

515Reads

47Profile Views

The Antioxidant Moiety of MitoQ Imparts Minimal Metabolic Effects in Adipose Tissue of High Fat Fed Mice.

Front Physiol 2019 8;10:543. Epub 2019 May 8.

Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2019.00543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517842PMC
May 2019

The CCC Complex COMManDs Control of LDL Cholesterol Levels.

Circ Res 2018 06;122(12):1629-1631

From the Lipid Metabolism and Cardiometabolic Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.F.K., A.C.C.)

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.31307
Publisher Site
http://dx.doi.org/10.1161/CIRCRESAHA.118.313074DOI Listing
June 2018

The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and Atherosclerosis.

Methods Mol Biol 2017 ;1583:65-72

Lipid Metabolism and Cardiometabolic Disease Laboratory, Baker IDI Heart and Diabetes Institute, St Kilda Rd Central, 6492, Melbourne, VIC, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6875-6_6DOI Listing
February 2018

Thrombosis in diabetes: a shear flow effect?

Clin Sci (Lond) 2017 Jun;131(12):1245-1260

Lipid Metabolism and Cardiometabolic Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20160391DOI Listing
June 2017

Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.

J Mol Endocrinol 2017 05 3;58(4):R225-R240. Epub 2017 Apr 3.

Central Clinical SchoolMonash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/JME-16-0249DOI Listing
May 2017

Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.

Arterioscler Thromb Vasc Biol 2016 Feb 29;36(2):295-307. Epub 2015 Dec 29.

From the Diabetic Complications Laboratory (S.P.G., E.D.M., K.K., P.C., M.E.C., K.A.M.J.-D.), Epigenetics Laboratory (J.O., A.E.-O.), and Diabetes and Dyslipidaemia Group (A.C.C.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Faculty of Medicine, Monash University, Melbourne, Australia (S.P.G., E.D.M., K.A.M.J.-D.); Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands (E.A.L.B.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.); and Department of Pharmacology, Cardiovascular Research Institute Maastricht (CARIM), Faculty of Medicine, Health, and Life Science, Maastricht University, Maastricht, The Netherlands (H.H.H.W.S.).

View Article

Download full-text PDF

Source
http://atvb.ahajournals.org/content/36/2/295.full.pdf
Web Search
http://atvb.ahajournals.org/lookup/doi/10.1161/ATVBAHA.115.3
Publisher Site
http://dx.doi.org/10.1161/ATVBAHA.115.307012DOI Listing
February 2016

Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.

J Biol Chem 2015 Feb 2;290(9):5566-81. Epub 2014 Dec 2.

From the David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, Iris Cantor-UCLA Women's Health Center, Los Angeles, California 90095

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.606459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342471PMC
February 2015

Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.

Circ Res 2014 Aug 16;115(4):442-9. Epub 2014 Jun 16.

From the Departments of Pathology and Laboratory Medicine (A.C.C., S.D.L., X.-H.W., C.H., P.T.), Department of Medicine, Division of Endocrinology (J.K., C.M.W.V.S., R.I.T.), Department of Medicine, Division of Cardiology (X.-H.W., A.J.L.), and Departments of Human Genetics and Microbiology Immunology and Molecular Genetics (A.J.L.), David Geffen School of Medicine, University of California, Los Angeles; Howard Hughes Medical Institute, Los Angeles, CA (A.C.C., S.D.L., C.H., P.T.); and Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (A.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.115.304440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119488PMC
August 2014

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Nat Rev Mol Cell Biol 2012 Mar 14;13(4):213-24. Epub 2012 Mar 14.

Howard Hughes Medical Institute, Department of Pathology and Laboratory Medicine, University of California, 675 Charles E Young Drive South, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrm3312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597092PMC
March 2012

FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.

Proc Natl Acad Sci U S A 2011 Dec 22;108(50):20107-12. Epub 2011 Nov 22.

Howard Hughes Medical Institute and Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1111589108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250164PMC
December 2011

PPAR Agonists and Cardiovascular Disease in Diabetes.

PPAR Res 2008 ;2008:245410

JDRF Center for Diabetes Complications, Baker Heart Research Institute, Melbourne, VIC 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2008/245410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233765PMC
July 2011

The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.

Genes Dev 2011 Jun;25(12):1262-74

Howard Hughes Medical Institute, University of California at Los Angeles School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.2056211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127428PMC
June 2011

The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

Am J Physiol Renal Physiol 2010 Sep 16;299(3):F528-35. Epub 2010 Jun 16.

Baker IDI Heart and Diabetes Institute, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00127.2010DOI Listing
September 2010

Genome-wide association studies identify new targets in cardiovascular disease.

Sci Transl Med 2010 Sep;2(48):48ps46

Howard Hughes Medical Institute and Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/cgi/doi/10.1126/scitranslmed.30015
Publisher Site
http://dx.doi.org/10.1126/scitranslmed.3001557DOI Listing
September 2010

Liver x receptor signaling pathways and atherosclerosis.

Arterioscler Thromb Vasc Biol 2010 Aug;30(8):1513-8

Howard Hughes Medical Institute, University of California at Los Angeles, School of Medicine, Box 951662, Los Angeles, CA 90095-1662, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.109.191197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919217PMC
August 2010

Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.

Circulation 2009 Nov 9;120(21):2095-104. Epub 2009 Nov 9.

Diabetes Complications Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Australia 8008.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.870709DOI Listing
November 2009

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.

Diabetes 2008 Sep 28;57(9):2461-9. Epub 2008 May 28.

Albert Einstein Juvenile Diabetes Research Foundation Centre for Diabetes Complications, Diabetes Metabolism Division, Baker Heart Research Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db07-1808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518498PMC
September 2008

Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.

Atherosclerosis 2007 Nov 9;195(1):17-22. Epub 2007 Jan 9.

Danielle Alberti Memorial Centre for Diabetic Complications, Baker Medical Research Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2006.11.021DOI Listing
November 2007

The clot thickens--oxidized lipids and thrombosis.

Nat Med 2007 Sep;13(9):1015-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0907-1015DOI Listing
September 2007

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Circulation 2007 Apr 9;115(16):2178-87. Epub 2007 Apr 9.

Oxidative Stress Group, JDRF Diabetes and Metabolism Division, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, VIC 8008, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.664250DOI Listing
April 2007

Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist.

Curr Opin Investig Drugs 2007 Apr;8(4):324-30

Baker Heart Research Institute, Juvenile Diabetes Research Foundation Centre for Diabetes Complications, PO Box 6492, St Kilda Road Central, Melbourne 8008, Australia.

View Article

Download full-text PDF

Source
April 2007

Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.

Am J Cardiovasc Drugs 2006 ;6(1):15-40

JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Baker Heart Research Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00129784-200606010-00003DOI Listing
October 2006

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.

Nephrol Dial Transplant 2006 Sep 23;21(9):2399-405. Epub 2006 May 23.

JDRF Danielle Alberti Memorial Centre for Diabetes complications, Baker Heart Research Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfl212DOI Listing
September 2006

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.

Arterioscler Thromb Vasc Biol 2005 Sep 14;25(9):1903-9. Epub 2005 Jul 14.

JDRF Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne 8008, Australia.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/01.ATV.0000177813.99
Publisher Site
http://dx.doi.org/10.1161/01.ATV.0000177813.99577.6bDOI Listing
September 2005

Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.

J Am Soc Nephrol 2005 Feb 29;16(2):363-73. Epub 2004 Dec 29.

Baker Heart Research Institute, P.O. Box 6492, Commercial Road, Melbourne 8008, VIC 3004, Australia.

View Article

Download full-text PDF

Source
http://jasn.asnjournals.org/content/16/2/363.full.pdf
Web Search
http://www.jasn.org/cgi/doi/10.1681/ASN.2004050392
Publisher Site
http://dx.doi.org/10.1681/ASN.2004050392DOI Listing
February 2005

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

J Am Soc Nephrol 2004 Aug;15(8):2125-38

Danielle Alberti Memorial Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ASN.0000133025.23732.46DOI Listing
August 2004

MK-767. Kyorin/Banyu/Merck.

Curr Opin Investig Drugs 2003 Apr;4(4):444-8

Danielle Alberti Memorial Centre for Diabetic Complications, Baker Medical Research Institute, St Kilda Rd Central, Melbourne, Victoria 8008, Australia.

View Article

Download full-text PDF

Source
April 2003